Background
The high prevalence and severity of methamphetamine (MA) abuse demands greater neurobiological understanding of its etiology.
Methods
Here, we conducted immunoblotting and in vivo microdialysis procedures in Methamphetamine High/Low Drinking (MAH/LDR) mice, as well as in isogenic C57BL/6J mice that varied in their MA-preference/taking, to examine the glutamate underpinnings of MA abuse vulnerability. Neuropharmacological and Homer2 knock-down approaches were also employed in C57BL/6J mice to confirm the role for nucleus accumbens glutamate/Homer2 expression in MA preference/aversion.
Results
We identified a hyper-glutamatergic state within the nucleus accumbens (NAC) as a biochemical trait corresponding with both genetic and idiopathic vulnerability for high MA-preference and -taking. We also confirmed that subchronic, subtoxic MA experience elicits a hyper-glutamatergic state within the NAC during protracted withdrawal, characterized by elevated mGlu1/5 receptor function and Homer2 receptor-scaffolding protein expression. A high MA-preferring phenotype was recapitulated by elevating endogenous glutamate within the NAC shell of mice and we reversed MA-preference/taking by lowering endogenous glutamate and/or Homer2 expression within this subregion.
Conclusions
Our data point to an idiopathic, genetic or drug-induced hyper-glutamatergic state within the NAC as a mediator of MA addiction vulnerability.